2 papers in the library · 36 citations · publishing 2024
Journal of Pain Research March 1, 2024 Christopher L. Robinson, Alexandra Fonseca, Efemena Diejomaoh et al. 32 citations
Psychedelics may have potential in alleviating pain symptoms secondary to a multitude of chronic pain conditions. However, further randomized, double-blind, placebo-controlled trials are needed to further explore and evaluate the role of psychedelics in chronic, non-cancer pain.
Journal of Pain Research 2024 Christopher L. Robinson, Matthew Slitzky, Michael E Schatman et al. 4 citations
Psychedelics, substances with a long history of cultural and medicinal use, are experiencing a resurgence in clinical research, particularly in psychiatry. Despite their classification as Schedule I drugs, recent studies suggest therapeutic potential, particularly in treating refractory depression. With chronic pain representing a major health concern and with few non-opioid treatment options...